Life After CAR T Therapy: Insights for Patients and Referring Oncologists
This video segment focuses on key elements of patient education and support for long-term CAR-T survivors, strategies to maintain quality of life and manage late effects, differences in supportive care needs between ide-cel and cilta-cel recipients, and approaches to fostering collaboration between academic centers and community practices for optimal long-term care.
Video content above is prompted by the following:
- What are the key elements of patient education and support for long-term CAR-T survivors?
- How do you help patients maintain their quality of life and manage potential late effects of treatment?
- Are there any differences in long-term supportive care needs between ide-cel and cilta-cel recipients?
- How can academic centers and community practices best collaborate to provide optimal long-term care for CAR-T patients?
- What resources or training programs have you found most beneficial for community oncologists managing CAR-T survivors?
- How do you handle the referral process for long-term follow-up between community and academic centers?
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
